Ngo et al, in The Protein Folding Problem and Tertiary Structure Prediction, 1994. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.* |
Mikayama et al. (PNAS, 1993. 90: 10056-10060).* |
Skolnick and Fetrow (Trends in Biotechnology, 2000. 18(1): 34-39).* |
Anderson (Nature 1998; 392(Supp): 25-30).* |
Spitler LE (Cancer Biotherapy 1995; 10(1): 1-3).* |
Burgess et al J Cell Biol. 111:2129-2138, 1990.* |
Lazar et al. Mol Cell Biol. 8:1247-1252, 1988.* |
Burden and Yarden, “Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis,” Neuron 18:847-855, Jun. 1997. |
Ben-Baruch et al., Hormones and Growth Factors in Development and Neoplasia, Wiley-Liss, Inc., Academic Publishers: Boston, 1998, Chapter 8, “Developmental and Physiologic Roles of ErbB Receptors and Their Ligands in Mammals,” pp. 145-168. |
Carraway III et al., “Heregulin Stimulates Mitogenesis and Phosphatidylinositol 3-Kinase in Mouse Fibroblasts Transfected with erbB2/neu and erbB3,” The Journal of Biological Chemistry 270(13): 7111-7116, Mar. 31, 1995. |
Carraway III, K., “Involvement of the neuregulins and their receptors in cardiac and neural development,” BioEssays 18(4): 263-266, 1996. |
Carraway III and Burden, “Neuregulins and their receptors,” Current Opinion in Neurobiology 5:606-612, 1995. |
Carraway III et al., “Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosins kinases,” Nature 387: 512-516, May 1997. |
Carroll et al., “Expression of Neuregulins and their Putative Receptors, ErbB2 and ErbB3, Is Induced during Wallerian Degeneration,” The Journal of Neuroscience 17(5): 1642-1659, Mar. 1997. |
Gassmann et al., “Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor,” Nature 378: 390-394, Nov. 1995. |
Harari et al., “Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase,” Oncogene 18: 2681-2689, 1999. |
Lee et al., “Requirement for neuregulin receptor erbB2 in neural and cardiac development,” Nature 378: 394-398, Nov. 23, 1995. |
Meyer and Birchmeier, “Multiple essential functions of neuregulin in development,” Nature 378: 386-390, Nov. 23, 1995. |
Morrissey et al., “Axon-induced mitogenesis of human schwann cells involves heregulin and p185erbB2,” Proceedings of the National Academy of Science USA 92: 1431-1435, Feb. 1995. |
Peles and Yarden, “Neu and its Ligands: From an Oncogene to Neural Factors,” BioEssays 15(12): 815-824, Dec. 1993. |
Pinkas-Kramarski et al., “ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network,” Molecular and Cellular Biology 18(10): 6090-6101, Oct. 1998. |
Pinkas-Kramarski et al., “Brain neurons and glial cells express Neu differentiation factor/heregulin: A survival factor for astrocytes,” Proceedings of the National Academy of Science USA 91:9387-9391, Sep. 1994. |
Tzahar et al., “ErbB-3 and ErbB-4 Function as the Respective Low and High Affinity Receptors of ALl Neu Differentiation Factor/heregulin Isoforms,” The Journal of Biological Chemistry 269(40): 25226-25233, Oct. 7, 1994. |
Zhang et al., “Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4,” Proceedings of the National Academy of Science 94: 9562-9567, Sep. 1997. |
Pinkas-Rramarski et al., Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions, EMBO Jour., 1995, 15:2452-2467. |
Shelly et al., Epiregulin Is a Potent Pan-ErbB Ligand That Perferentailly Activates Heterodimeric Receptor Complexes, J. Biol. Chem., 1998, pp. 10496-10505, 273:17. |
Sepp-Lorenzino, et al., Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells, Oncogene, 1996, 12: 1679-1687. |